2
804 Journal of Medicinal Chemistry, 2009, Vol. 52, No. 9
Stubbs et al.
succinate, fumarate, 2,4-PDCA, BIC and its L-Ala and D-Ala
derivatives. Details for the synthesis of L-Ala and D-Ala derivatives
of BIC. This material is available free of charge via the Internet at
http://pubs.acs.org.
(21) Mole, D. R.; Schlemminger, I.; McNeill, L. A.; Hewitson, K. S.; Pugh,
C. W.; Ratcliffe, P. J.; Schofield, C. J. 2-Oxoglutarate Analogue
Inhibitors of HIF Prolyl Hydroxylase. Bioorg. Med. Chem. Lett. 2003,
1
3, 2677–2680.
(
22) Ratan, R. R.; Siddiq, A.; Aminova, L.; Lange, P. S.; Langley, B.;
Ayoub, I.; Gensert, J.; Chavez, J. Translation of ischemic precondi-
tioning to the patient: prolyl hydroxylase inhibition and hypoxia
inducible factor-1 as novel targets for stroke therapy. Stroke 2004,
References
(
1) Fontana, A.; de Laureto, P. P.; Spolaore, B.; Frare, E.; Picotti, P.;
Zambonin, M. Probing protein structure by limited proteolysis. Acta
Biochim. Pol. 2004, 51, 299–321.
3
5, 2687–2689.
(
23) Warshakoon, N. C.; Wu, S.; Boyer, A.; Kawamoto, R.; Sheville, J.;
Renock, S.; Xu, K.; Pokross, M.; Zhou, S.; Winter, C.; Walter, R.;
Mekel, M.; Evdokimov, A. G. Structure-based design, synthesis, and
SAR evaluation of a new series of 8-hydroxyquinolines as HIF-1alpha
prolyl hydroxylase inhibitors. Bioorg. Med. Chem. Lett. 2006, 16,
(
2) Sajnani, G.; Pastrana, M. A.; Dynin, I.; Onisko, B.; Requena, J. R. Scrapie
prion protein structural constraints obtained by limited proteolysis and
mass spectrometry. J. Mol. Biol. 2008, 382, 88-
9
8.
5
517–5522.
(
(
(
3) Cohen, S. L.; Ferre-D’Amare, A. R.; Burley, S. K.; Chait, B. T. Probing
the solution structure of the DNA-binding protein Max by a combina-
tion of proteolysis and mass spectrometry. Protein Sci. 1995, 4, 1088–
(
(
24) Epstein, A. C. R.; Gleadle, J. M.; McNeill, L. A.; Hewitson, K. S.;
O’Rourke, J.; Mole, D. R.; Mukherji, M.; Metzen, E.; Wilson, M. I.;
Dhanda, A.; Tian, Y. M.; Masson, N.; Hamilton, D. L.; Jaakkola, P.;
Barstead, R.; Hodgkin, J.; Maxwell, P. H.; Pugh, C. W.; Schofield,
C. J.; Ratcliffe, P. J. C. elegans EGL-9 and mammalian homologs
define a family of dioxygenases that regulate HIF by prolyl hydroxy-
lation. Cell 2001, 107, 43–54.
1
099.
4) Gervasoni, P.; Staudenmann, W.; James, P.; Pl u¨ ckthun, A. Identifica-
tion of the binding surface on beta-lactamase for GroEL by limited
proteolysis and MALDI-mass spectrometry. Biochemistry 1998, 37,
1
1660–11669.
25) Elkins, J. M.; Hewitson, K. S.; McNeill, L. A.; Seibel, J. F.;
Schlemminger, I.; Pugh, C. W.; Ratcliffe, P. J.; Schofield, C. J.
Structure of factor-inhibiting hypoxia-inducible factor (HIF) reveals
mechanism of oxidative modification of HIF-1R. J. Biol. Chem. 2003,
5) Krekel, F.; Oecking, C.; Amrhein, N.; Macheroux, P. Substrate and
inhibitor-induced conformational changes in the structurally related
enzymes UDP-N-acetylglucosamine enolpyruvyl transferase (MurA)
and 5-enolpyruvylshikimate 3-phosphate synthase (EPSPS). Biochem-
istry 1999, 38, 8864–8878.
2
78, 1802–1806.
(
6) Lacy, E. R.; Wang, Y.; Post, J.; Nourse, A.; Webb, W.; Mapelli, M.;
Musacchio, A.; Siuzdak, G.; Kriwacki, R. W. Molecular basis for the
specificity of p27 toward cyclin-dependent kinases that regulate cell
division. J. Mol. Biol. 2005, 349, 764–773.
(26) Ng, S. S.; Kavanagh, K. L.; McDonough, M. A.; Butler, D.; Pilka,
E. S.; Lienard, B. M.; Bray, J. E.; Savitsky, P.; Gileadi, O.; von Delft,
F.; Rose, N. R.; Offer, J.; Scheinost, J. C.; Borowski, T.; Sundstrom,
M.; Schofield, C. J.; Oppermann, U. Crystal structures of histone
demethylase JMJD2A reveal basis for substrate specificity. Nature
(London) 2007, 448, 87–91.
(27) You, Z.; Omura, S.; Ikeda, H.; Cane, D. E.; Jogl, G. Crystal structure
of the non-heme iron dioxygenase PtlH in pentalenolactone biosyn-
thesis. J. Biol. Chem. 2007, 282, 36552–36560.
(
7) Yang, F.; Cheng, Y.; Peng, J.; Zhou, J.; Jing, G. Probing the
conformational state of a truncated staphylococcal nuclease R using
time-of-flight mass spectrometry with limited proteolysis. Eur. J. Bio-
chem. 2001, 268, 4227–4232.
(8) Semenza, G. L. Hypoxia-inducible factor 1 (HIF-1) pathway. Sci. STKE
2
007, 407, cm8.
(28) Hewitson, K. S.; Li e´ nard, B. M.; McDonough, M. A.; Clifton, I. J.;
Butler, D.; Soares, A. S.; Oldham, N. J.; McNeill, L. A.; Schofield,
C. J. Structural and mechanistic studies on the inhibition of the
hypoxia-inducible transcription factor hydroxylases by tricarboxylic
acid cycle intermediates. J. Biol. Chem. 2007, 282, 3293–3301.
(29) King, A.; Selak, M. A.; Gottlieb, E. Succinate dehydrogenase and
fumarate hydratase: linking mitochondrial dysfunction and cancer.
Oncogene 2006, 25, 4675–4682.
(
9) Chowdhury, R.; Hardy, A.; Schofield, C. J. The human oxygen sensing
machinery and its manipulation. Chem. Soc. ReV. 2008, 37, 1308–1319.
(
(
10) Ivan, M.; Kondo, K.; Yang, H. F.; Kim, W.; Valiando, J.; Ohh, M.;
Salic, A.; Asara, J. M.; Lane, W. S.; Kaelin, W. G. HIF alpha targeted
for VHL-mediated destruction by proline hydroxylation: Implications
for O-2 sensing. Science 2001, 292, 464–468.
11) Jaakkola, P.; Mole, D. R.; Tian, Y. M.; Wilson, M. I.; Gielbert, J.;
Gaskell, S. J.; von Kriegsheim, A.; Hebestreit, H. F.; Mukherji, M.;
Schofield, C. J.; Maxwell, P. H.; Pugh, C. W.; Ratcliffe, P. J. Targeting
of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by
(
30) Koivunen, P.; Hirsil a¨ , M.; Remes, A. M.; Hassinen, I. E.; Kivirikko,
K. I.; Myllyharju, J. Inhibition of hypoxia-inducible factor (HIF)
hydroxylases by citric acid cycle intermediates: possible links between
cell metabolism and stabilization of HIF. J. Biol. Chem. 2007, 282,
O
2
-regulated prolyl hydroxylation. Science 2001, 292, 468–472.
12) Ke, Q.; Costa, M. Hypoxia-inducible factor-1 (HIF-1). Mol. Pharmacol.
006, 70, 1469–1480.
(
(
(
4
524–4532.
2
(
31) Pollard, P. J.; Bri e` re, J. J.; Alam, N. A.; Barwell, J.; Barclay, E.;
Wortham, N. C.; Hunt, T.; Mitchell, M.; Olpin, S.; Moat, S. J.;
Hargreaves, I. P.; Heales, S. J.; Chung, Y. L.; Griffiths, J. R.; Dalgleish,
A.; McGrath, J. A.; Gleeson, M. J.; Hodgson, S. V.; Poulsom, R.;
Rustin, P.; Tomlinson, I. P. Accumulation of Krebs cycle intermediates
and over-expression of HIF1alpha in tumours which result from
germline FH and SDH mutations. Hum. Mol. Genet. 2005, 14, 2231–
13) Hewitson, K. S.; Schofield, C. J. The HIF pathway as a therapeutic
target. Drug DiscoVery Today 2004, 9, 704–711.
14) Clifton, I. J.; McDonough, M. A.; Ehrismann, D.; Kershaw, N. J.;
Granatino, N.; Schofield, C. J. Structural studies on 2-oxoglutarate
oxygenases and related double-stranded beta-helix fold proteins.
J. Inorg. Biochem. 2006, 100, 644–669.
(
15) Hausinger, R. P. Fe(II)/R-ketoglutarate-dependent hydroxylases and
related enzymes. Crit. ReV. Biochem. Mol. Biol. 2004, 39, 21–68.
16) Bleijlevens, B.; Shivarattan, T.; Flashman, E.; Yang, Y.; Simpson,
P. J.; Koivisto, P.; Sedgwick, B.; Schofield, C. J.; Matthews, S. J.
Dynamic states of the DNA repair enzyme AlkB regulate product
release. EMBO Rep. 2008, 9, 872–877.
2
239.
(
(
(
32) Majamaa, K.; Hanauske-Abel, H. M.; G u¨ nzler, V.; Kivirikko, K. I.
The 2-oxoglutarate binding site of prolyl 4-hydroxylase. Eur. J. Bio-
chem. 1984, 138, 239–245.
33) Hirsilä, M.; Koivunen, P.; G u¨ nzler, V.; Kivirikko, K. I.; Myllyharju,
J. Characterization of the human prolyl 4-hydroxylases that modify
the hypoxia-inducible factor. J. Biol. Chem. 2003, 278, 30772–30780.
34) Warshakoon, N. C.; Wu, S.; Boyer, A.; Kawamoto, R.; Sheville, J.;
Renock, S.; Xu, K.; Pokross, M.; Evdokimov, A. G.; Walter, R.;
Mekel, M. A novel series of imidazo[1,2-a]pyridine derivatives as
HIF-1alpha prolyl hydroxylase inhibitors. Bioorg. Med. Chem. Lett.
(
(
17) Flashman, E.; Bagg, E. A. L.; Chowdhury, R.; Mecinovi c´ , J.; Loenarz,
C.; McDonough, M. A.; Hewitson, K. S.; Schofield, C. J. Kinetic
Rationale for Selectivity toward N- and C-terminal Oxygen-dependent
Degradation Domain Substrates Mediated by a Loop Region of
Hypoxia-Inducible Factor Prolyl Hydroxylases. J. Biol. Chem. 2008,
2
83, 3808–3815.
2
006, 16, 5598–5601.
(
18) McDonough, M. A.; Li, V.; Flashman, E.; Chowdhury, R.; Mohr, C.;
Li e´ nard, B. M.; Zondlo, J.; Oldham, N. J.; Clifton, I. J.; Lewis, J.;
McNeill, L. A.; Kurzeja, R. J.; Hewitson, K. S.; Yang, E.; Jordan, S.;
Syed, R. S.; Schofield, C. J. Cellular oxygen sensing: crystal structure
of hypoxia-inducible factor prolyl hydroxylase (PHD2). Proc. Natl.
Acad. Sci. U.S.A. 2006, 103, 9814–9819.
19) McDonough, M. A.; McNeill, L. A.; Tilliet, M.; Papamica e¨ l, C. A.;
Chen, Q. Y.; Banerji, B.; Hewitson, K. S.; Schofield, C. J. Selective
inhibition of factor inhibiting hypoxia-inducible factor. J. Am. Chem.
Soc. 2005, 127, 7680–7681.
(
35) Hewitson, K. S.; McNeill, L. A.; Riordan, M. V.; Tian, Y. M.; Bullock,
A. N.; Welford, R. W. D.; Elkins, J. M.; Oldham, N. J.; Battacharya,
S.; Gleadle, J.; Ratcliffe, P. J.; Pugh, C. W.; Schofield, C. J. Hypoxia
inducible factor (HIF) asparagine hydroxylase is identical to Factor
Inhibiting HIF (FIH) and is related to the cupin structural family.
J. Biol. Chem. 2002, 277, 26351–26355.
(
(
(
36) Lando, D.; Peet, D. J.; Gorman, J. J.; Whelan, D. A.; Whitelaw, M. L.;
Bruick, R. K. FIH-1 is an asparaginyl hydroxylase enzyme that
regulates the transcriptional activity of hypoxia-inducible factor. Genes
DeV. 2002, 16, 1466–1471.
20) McNeill, L. A.; Flashman, E.; Buck, M. R.; Hewitson, K. S.; Clifton,
I. J.; Jeschke, G.; Claridge, T. D.; Ehrismann, D.; Oldham, N. J.;
Schofield, C. J. Hypoxia-inducible factor prolyl hydroxylase 2 has a
high affinity for ferrous iron and 2-oxoglutarate. Mol. BioSyst. 2005,
(37) Schofield, C. J.; Ratcliffe, P. J. Oxygen sensing by HIF hydroxylases.
Nat. ReV. Mol. Cell Biol. 2004, 5, 343–354.
(38) Dao, J. H.; Kurzeja, R. J.; Morachis, J. M.; Veith, H.; Lewis, J.; Yu,
V.; Tegley, C. M.; Tagari, P. Kinetic characterization and identification
1
, 321–324.